Cost Effective Supplement

Study

Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. – Cost Effective Supplements

Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.

Quick navigation

http://www.ncbi.nlm.nih.gov/pubmed/25046624

Conclusion of this study

Partial support is provided for the antidepressant effects of curcumin in people with major depressive disorder, evidenced by benefits occurring 4 to 8 weeks after treatment.

Supplements analyzed in this study

Curcumin

Health conditions analyzed in this study

Anxiety


Slightly Positive
Curcumin
Depression


Moderately Positive
Curcumin

Functions related to this study

Emotional health


Moderately Positive
Curcumin

Body systems related to this study


Nervous System
Curcumin
Scroll to top